Evaluation and use of childhood lung function tests in cystic fibrosis

Current Opinion in Pulmonary Medicine

Volumn 18, Issue 6, 2012, Pages 602-608

  Stocks, Janet ^a   Thia, Lena P ^a   Sonnappa, Samatha ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

cystic fibrosis; infants; outcome measures; preschool child; pulmonary function tests

Indexed keywords

CLINICAL EVALUATION; CLINICAL TRIAL; CYSTIC FIBROSIS; HUMAN; LUNG CLEARANCE; LUNG DISEASE; LUNG FUNCTION TEST; OUTCOME ASSESSMENT; PEDIATRICS; PRACTICE GUIDELINE; REVIEW; SPIROMETRY;

BREATH TESTS; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DISEASE PROGRESSION; HUMANS; INFANT; OUTCOME ASSESSMENT (HEALTH CARE); PLETHYSMOGRAPHY; RESPIRATORY FUNCTION TESTS; SPIROMETRY;

EID: 84867023209     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328358dfbe     Document Type: Review

References (70)

1. Buzzetti R, Salvatore D, Baldo E, et al. An overview of international literature from cystic fibrosis registries: 1. Mortality and survival studies in cystic fibrosis. J Cyst Fibros 2009; 8:229-237.
2. Ramsey BW, Banks-Schlegel S, Accurso FJ, et al. Future directions in early cystic fibrosis lung disease research: an NHLBI workshop report. Am J Respir Crit Care Med 2012; 185:887-892.
3. Sly PD, Ware RS, de Klerk N, Stick SM. Randomised controlled trials in cystic fibrosis: what, when and how? Eur Respir J 2011; 37:991-993.
4. Stick SM, Sly PD. Exciting new clinical trials in cystic fibrosis: infants need not apply. Am J Respir Crit Care Med 2011; 183:1577-1578.
5. Stocks J, Lum S. Pulmonary function tests in infants and preschool children. In: Wilmott RW, Boat TF, Bush A, et al., editors. Kendig's disorders of the respiratory tract in children. 8th ed. Philadelphia, PA, USA: Elsevier; 2012. pp. 169-210.
6. Gappa M, Ranganathan S, Stocks J. Lung function testing in infants with cystic fibrosis: lessons from the past and future directions. Pediatr Pulmonol 2001; 32:228-245.
7. Beydon N, Davis SD, Lombardi E, et al. An official American Thoracic Society/European Respiratory Society statement: Pulmonary function testing in preschool children. Am J Respir Crit Care Med 2007; 175:1304-1345.
8. Lum S, Stocks J, Castile R, et al. ATS/ERS statement: raised volume forced expirations in infants-guidelines for current practice. Am J Respir Crit Care Med 2005; 172:1463-1471.
9. Rosenfeld M, Allen J, Arets HG, et al. Optimal lung function tests for monitoring cystic fibrosis, bronchopulmonary dysplasia and recurrent wheezing in children <6 years of age. Am J Respir Crit Care Med (in press).
10. Stanojevic S, Wade A, Lum S, Stocks J. Reference equations for pulmonary function tests in preschool children: a review. Pediatr Pulmonol 2007; 42:962-972.
11. Stanojevic S, Wade A, Stocks J. Reference values for lung function: past, present and future. Eur Respir J 2010; 36:12-19.
12. Ranganathan S, Dezateux CA, Bush A, et al. Airway function in infants newly diagnosed with cystic fibrosis. Lancet 2001; 358:1964-1965.
13. Ranganathan SC, Gappa M. Cystic fibrosis. In: Merkus PJ, Frey U, editors. Paediatric lung function. Sheffield: ERS Journals Limited; 2010. pp. 225-239.
14. Kozlowska W, Bush A, Wade A, et al. Lung function from infancy to the preschool years after clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med 2008; 178:42-49.
15. Aurora P, Stanojevic S, Wade A, et al. Lung clearance index at 4 years predicts subsequent lung function in children with cystic fibrosis. Am J Respir Crit Care Med 2011; 183:752-758.
16. Dijk FN, McKay K, Barzi F, et al. Improved survival in cystic fibrosis patients diagnosed by newborn screening compared to a historical cohort from the same centre. Arch Dis Child 2011; 96:1118-1123.
17. Lum S, Stocks J. Forced expiratory manoeuvres. In: Merkus P, Frey U, editors. Paediatric lung function. ERS Journals Ltd; 2010. pp. 46-65.
18. Quanjer PH, Stanojevic S, Cole TJ, et al. Multiethnic reference values for spirometry for the 3-95 year age range: the global lung function 2012 equations. Eur Respir J 2012. doi: 10.1183/09031936.00080312. http://erj.ersjournals.com/cgi/content/abstract/09031936.00080312v1?papetoc
19. Aurora P. Multiple-breath inert gas washout test and early cystic fibrosis lung disease. Thorax 2010; 65:373-374.
20. Gustafsson PM, de Jong PA, Tiddens HA, Lindblad A. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Thorax 2008; 63:129-134.
21. Tiddens HA, Donaldson SH, Rosenfeld M, Pare PD. Cystic fibrosis lung disease starts in the small airways: can we treat it more effectively? Pediatr Pulmonol 2010; 45:107-117.
22. Lum S, Gustafsson P, Ljungberg H, et al. Early detection of cystic fibrosis lung disease: multiple-breath washout vs. raised volume tests. Thorax 2007; 62:341-347.
23. Linnane BM, Hall GL, Nolan G, et al. Lung function in infants with cystic fibrosis diagnosed by newborn screening. Am J Respir Crit Care Med 2008; 178:1238-1244.
24. Hoo A-F, Thia L, Nguyen TD, et al., on behalf of the London Cystic Fibrosis Collaboration (LCFC). Lung function is abnormal in 3 month old infants with cystic fibrosis diagnosed by newborn screening. Thorax 2012; 67:874-881.
25. Davis SD, Rosenfeld M, Kerby GS, et al. Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints. Am J Respir Crit Care Med 2010; 182:1387-1397.
26. Fuchs SI, Gappa M. Lung clearance index: clinical and research applications in children. Paediatr Respir Rev 2011; 12:264-270.
27. Gustafsson PM. Inert gas washout in preschool children. Paediatr Respir Rev 2005; 6:239-245.
28. Gustafsson PM. Editorial: preschool lung function testing-the missing link. Paediatr Respir Rev 2005; 6:237-238.
29. Robinson PD, Goldman MD, Gustafsson PM. Inert gas washout: theoretical background and clinical utility in respiratory disease. Respiration 2009; 78:339-355.
30. Robinson PD, Lindblad A, Gustafsson PM. Comparison of the utility of multiple breath inert gas washout parameters in cystic fibrosis. Thorax 2010; 65:659.
31. Fuchs SI, Gappa M. Equipment for multiple breath washout. Eur Respir J 2010; 35:458-459.
32. Horsley A. Lung clearance index in the assessment of airways disease. Respir Med 2009; 103:793-799.
33. Horsley AR, Gustafsson PM, Macleod KA, et al. Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis. Thorax 2008; 63:135-140.
34. Kraemer R, Blum A, Schibler A, et al. Ventilation inhomogeneities in relation to standard lung function in patients with cystic fibrosis. Am J Respir Crit Care Med 2005; 171:371-378.
35. Latzin P, Sauteur L, Thamrin C, et al. Optimized temperature and deadspace correction improve analysis of multiple breath washout measurements by ultrasonic flowmeter in infants. Pediatr Pulmonol 2007; 42:888-897.
36. Robinson P, Latzin P, Verbank S, et al. Guidelines for inert gas washout measurement using multiple and single breath tests. Eur Respir J 2012 (in press).
37. Robinson P, Stocks J, Aurora P, Lum S. Abbreviated multibreath washout for calculation of Lung Clearance Index. Pediatr Pulmonol 2012 (in press).
38. Kirkby J, Stanojevic S, Welsh L, et al. Reference equations for specific airway resistance in children: the asthma UK initiative. Eur Respir J 2010; 36:622-629.
39. Aurora P, Bush A, Gustafsson P, et al. Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis. Am J Respir Crit Care Med 2005; 179:249-256.
40. Gangell CL, Hall GL, Stick SM, Sly PD. Lung function testing in preschool-aged children with cystic fibrosis in the clinical setting. Pediatr Pulmonol 2010; 45:419-433.
41. Kerby GS, Rosenfeld M, Ren CL, et al. Lung function distinguishes preschool children with CF from healthy controls in a multicenter setting. Pediatr Pulmonol 2012; 47:597-605.
42. Merkus P, Stocks J, Beydon N, et al. Reference ranges for interrupter resistance technique: the asthma UK initiative. Eur Respir J 2010; 36:157-163.
43. Lum S, Hoo AF, Hulskamp G, et al. Potential misinterpretation of infant lung function unless prospective healthy controls are studied. Pediatr Pulmonol 2010; 45:906-913.
44. Nguyen TTD, Hoo A-F, Lum S, et al. New reference equations to improve interpretation of infant lung function. Pediatr Pulmonol 2012 (in press). doi: 10.1002/ppul.22656.
45. Stocks J, Modi N, Tepper R. Need for healthy controls when assessing lung function in infants with respiratory disease. Am J Respir Crit Care Med 2010; 182:1340-1342.
46. Quanjer PH, Borsboom GJ, Kivastik J, et al. Cross-sectional and longitudinal spirometry in children and adolescents: interpretative strategies. Am J Respir Crit Care Med 2008; 178:1262-1270.
47. Kirkby J, Aurora P, Spencer H, et al. 'Stitching and Switching': the impact of discontinuous lung function reference equations. Eur Respir J 2012; 39:1256-1257.
48. Lum S, Stocks J, Stanojevic S, et al. Age and height dependence of lung clearance index and functional residual capacity. Eur Respir J 2012 (in press).
49. Haidopoulou K, Lum S, Turcu S, et al. Alveolar LCI vs. standard LCI in detecting early CF lung disease. Respir Physiol Neurobiol 2012; 180:247-251.
50. Kirkby J, Bonner R, Lum S, et al. Interpretation of pediatric lung function: Impact of ethnicity. Pediatr Pulmonol 2012. doi: 10.1002/ppul.22538.
51. Chudleigh J, Hoo A-F, Ahmed D, et al. Positive parental attitudes to partici-pating in research involving newborn screened infants with CF. J Cyst Fibros 2012 (in press).
52. Pillarisetti N, Williamson E, Linnane B, et al. Infection, inflammation, and lung function decline in infants with cystic fibrosis. Am J Respir Crit Care Med 2011; 184:75-81.
53. Thia L, Hoo A-F, Nguyen TD, et al. Improvement in lung function during the 1st year of life in infants diagnosed with CF through newborn screening (NBS). Eur Respir J 2011; 38(Suppl 55): 848s.
54. Ranganathan S, Stocks J, Dezateux C, et al. The evolution of airway function in infancy and early childhood following clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med 2004; 169:928-933.
55. Belessis Y, Dixon B, Hawkins G, et al. Early cystic fibrosis lung disease detected by bronchoalveolar lavage and lung clearance index. Am J Respir Crit Care Med 2012; 185:862-873.
56. Hall GL, Logie KM, Parsons F, et al. Air trapping on chest CT is associated with worse ventilation distribution in infants with cystic fibrosis diagnosed following newborn screening. PLoS One 2011; 6:e23932.
57. Ellemunter H, Fuchs SI, Unsinn KM, et al. Sensitivity of Lung Clearance Index and chest computed tomography in early CF lung disease. Respir Med 2010; 104:1834-1842.
58. Owens CM, Aurora P, Stanojevic S, et al. Lung Clearance Index and HRCT are complementary markers of lung abnormalities in young children with CF. Thorax 2011; 66:481-488.
59. Pittman JE, Johnson RC, Davis SD. Improvement in pulmonary function following antibiotics in infants with cystic fibrosis. Pediatr Pulmonol 2012; 47:441-446.
60. Rosenfeld M, Ratjen F, Brumback L, et al. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial. JAMA 2012; 307:2269-2277.
61. Konstan MW, Wagener JS, Yegin A, et al. Design and powering of cystic fibrosis clinical trials using rate of FEV decline as an efficacy endpoint. J Cyst Fibros 2010; 9:332-338.
62. Konstan MW, Wagener JS, Pasta DJ, et al. Clinical use of dornase alpha is associated with a slower rate of FEV1 decline in cystic fibrosis. Pediatr Pulmonol 2011; 46:545-553.
63. 1 decline in both adults and children with cystic fibrosis. Pediatr Pulmonol 2011; 46:393-400.
64. Ren CL, Rosenfeld M, Mayer OH, et al. Analysis of the associations between lung function and clinical features in preschool children with cystic fibrosis. Pediatr Pulmonol 2012; 47:574-581.
65. Robinson PD, Cooper P, Van AP, et al. Using index of ventilation to assess response to treatment for acute pulmonary exacerbation in children with cystic fibrosis. Pediatr Pulmonol 2009; 44:733-742.
66. Fuchs SI, Toussaint S, Edlhaimb B, et al. Short-term effect of physiotherapy on variability of the lung clearance index in children with cystic fibrosis. Pediatr Pulmonol 2010; 45:301-306.
67. Amin R, Subbarao P, Jabar A, et al. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function. Thorax 2010; 65:379-383.
68. Amin R, Subbarao P, Lou W, et al. The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis. Eur Respir J 2011; 37:806-812.
69. Hall GL, Stocks J. Intervention trials and ventilation distribution in mild cystic fibrosis lung disease; will it all come out in the wash? Eur Respir J 2011; 37:757-759.
70. Kraemer R, Thamrin C. Pulmonary outcome prediction for cystic fibrosis patients. Pediatr Pulmonol 2010; 45:1153-1155.